Targeting DNA repair pathways for cancer treatment: What's new?

Research output: Contribution to journalReview article

80 Citations (Scopus)

Abstract

Disruptions in DNA repair pathways predispose cells to accumulating DNA damage. A growing body of evidence indicates that tumors accumulate progressively more mutations in DNA repair proteins as cancers progress. DNA repair mechanisms greatly affect the response to cytotoxic treatments, so understanding those mechanisms and finding ways to turn dysregulated repair processes against themselves to induce tumor death is the goal of all DNA repair inhibition efforts. Inhibition may be direct or indirect. This burgeoning field of research is replete with promise and challenge, as more intricacies of each repair pathway are discovered. In an era of increasing concern about healthcare costs, use of DNA repair inhibitors can prove to be highly effective stewardship of R&D resources and patient expenses.

Original languageEnglish (US)
Pages (from-to)1215-1237
Number of pages23
JournalFuture Oncology
Volume10
Issue number7
DOIs
StatePublished - May 2014

Fingerprint

DNA Repair
Neoplasms
Therapeutics
Health Care Costs
DNA Damage
Mutation
Research
Proteins

Keywords

  • clinical trials
  • DNA repair inhibition
  • DNA repair pathways
  • DNA repair targets
  • small-molecule inhibitors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Targeting DNA repair pathways for cancer treatment : What's new? / Kelley, Mark R.; Logsdon, Derek; Fishel, Melissa L.

In: Future Oncology, Vol. 10, No. 7, 05.2014, p. 1215-1237.

Research output: Contribution to journalReview article

@article{c0eddd5fbcab486d948730c3923cd647,
title = "Targeting DNA repair pathways for cancer treatment: What's new?",
abstract = "Disruptions in DNA repair pathways predispose cells to accumulating DNA damage. A growing body of evidence indicates that tumors accumulate progressively more mutations in DNA repair proteins as cancers progress. DNA repair mechanisms greatly affect the response to cytotoxic treatments, so understanding those mechanisms and finding ways to turn dysregulated repair processes against themselves to induce tumor death is the goal of all DNA repair inhibition efforts. Inhibition may be direct or indirect. This burgeoning field of research is replete with promise and challenge, as more intricacies of each repair pathway are discovered. In an era of increasing concern about healthcare costs, use of DNA repair inhibitors can prove to be highly effective stewardship of R&D resources and patient expenses.",
keywords = "clinical trials, DNA repair inhibition, DNA repair pathways, DNA repair targets, small-molecule inhibitors",
author = "Kelley, {Mark R.} and Derek Logsdon and Fishel, {Melissa L.}",
year = "2014",
month = "5",
doi = "10.2217/fon.14.60",
language = "English (US)",
volume = "10",
pages = "1215--1237",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "7",

}

TY - JOUR

T1 - Targeting DNA repair pathways for cancer treatment

T2 - What's new?

AU - Kelley, Mark R.

AU - Logsdon, Derek

AU - Fishel, Melissa L.

PY - 2014/5

Y1 - 2014/5

N2 - Disruptions in DNA repair pathways predispose cells to accumulating DNA damage. A growing body of evidence indicates that tumors accumulate progressively more mutations in DNA repair proteins as cancers progress. DNA repair mechanisms greatly affect the response to cytotoxic treatments, so understanding those mechanisms and finding ways to turn dysregulated repair processes against themselves to induce tumor death is the goal of all DNA repair inhibition efforts. Inhibition may be direct or indirect. This burgeoning field of research is replete with promise and challenge, as more intricacies of each repair pathway are discovered. In an era of increasing concern about healthcare costs, use of DNA repair inhibitors can prove to be highly effective stewardship of R&D resources and patient expenses.

AB - Disruptions in DNA repair pathways predispose cells to accumulating DNA damage. A growing body of evidence indicates that tumors accumulate progressively more mutations in DNA repair proteins as cancers progress. DNA repair mechanisms greatly affect the response to cytotoxic treatments, so understanding those mechanisms and finding ways to turn dysregulated repair processes against themselves to induce tumor death is the goal of all DNA repair inhibition efforts. Inhibition may be direct or indirect. This burgeoning field of research is replete with promise and challenge, as more intricacies of each repair pathway are discovered. In an era of increasing concern about healthcare costs, use of DNA repair inhibitors can prove to be highly effective stewardship of R&D resources and patient expenses.

KW - clinical trials

KW - DNA repair inhibition

KW - DNA repair pathways

KW - DNA repair targets

KW - small-molecule inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84903192918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903192918&partnerID=8YFLogxK

U2 - 10.2217/fon.14.60

DO - 10.2217/fon.14.60

M3 - Review article

C2 - 24947262

AN - SCOPUS:84903192918

VL - 10

SP - 1215

EP - 1237

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 7

ER -